DT2216

· Dialectic Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DT2216, covering 2025-04-16 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer [Phase 1]